Imerys

29/11/19 -"Market conditions have significantly deteriorated, since H1 19, causing sales volumes to drop further than anticipated during Q3 19 and which were only partly offset by price-mix and the ramp-up of ..."

PDF page sample
Pages
62
Language
English
Published on
29/11/19
Download
You may also be interested by these reports :
02/12/19
Due to the difficult situations in the eastern Mediterranean in 9m 19, i.e. Egypt (11% of cement capacity) and its Army’s cement plant of some 10Mt ...
29/11/19
Market conditions have significantly deteriorated, since H1 19, causing sales volumes to drop further than anticipated during Q3 19 and which were ...
29/11/19
Following the lower financial performance of the North America division, i.e. EBITDA down by 9% lfl in Q3 despite a 6.5% increase in lfl revenue ...
28/11/19
As expected we have made only minor changes to our target price and we keep our Buy recommendation unchanged.

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO